Maspin, a prognostic marker for breast cancer?

被引：0
|
作者：
Zhang, PJ
Nolan, C
Driscoll, DL
Maggio, P
Brooks, JJ
机构：
[1] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY USA
[2] Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY USA
来源：
LABORATORY INVESTIGATION | 1998年 / 78卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
165
引用
收藏
页码：31A / 31A
页数：1
相关论文
共 50 条
  • [41] EVALUATION OF TUMOR ANGIOGENESIS AS A PROGNOSTIC MARKER IN BREAST-CANCER
    SIGHTLER, HE
    BOROWSKY, AD
    DUPONT, WD
    PAGE, DL
    JENSEN, RA
    LABORATORY INVESTIGATION, 1994, 70 (01) : A22 - A22
  • [42] The Contribution of Imaging as a Prognostic Marker of Luminal Breast Cancer COMMENT
    Kataoka, Masako
    RADIOLOGY, 2022, 304 (02) : 320 - 321
  • [43] Ki-67 as a prognostic marker in patients with breast cancer
    Lux, M. P.
    Schrauder, M.
    Loehberg, C. R.
    Wiesner, F. G.
    Beckmann, M. W.
    Fasching, P. A.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 : S57 - S57
  • [44] Ki-67 as a prognostic molecular marker in breast cancer
    Lux, M. P.
    Bani, M. R.
    Schrauder, M. G.
    Loehberg, C.
    Beckmann, K.
    Wiesner, F. G.
    Beckmann, M. W.
    Fasching, P. A.
    ONKOLOGIE, 2008, 31 : 50 - 51
  • [45] Foxo3a Expression Is a Prognostic Marker in Breast Cancer
    Jiang, Ying
    Zou, Lin
    Lu, Wei-Qi
    Zhang, Yong
    Shen, Ai-Guo
    PLOS ONE, 2013, 8 (08):
  • [46] GATA-3 as a new prognostic marker in breast cancer
    Kim, L. S.
    Lee, Y.
    Lim, Y. -A.
    BREAST, 2011, 20 : S40 - S40
  • [47] HER2 as a prognostic and predictive marker for breast cancer
    Cooke, T
    Reeves, J
    Lanigan, A
    Stanton, P
    ANNALS OF ONCOLOGY, 2001, 12 : 23 - 28
  • [48] CA 15-3: a prognostic marker in breast cancer
    Duffy, MJ
    Shering, S
    Sherry, F
    McDermott, E
    O'Higgins, N
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (04): : 330 - 333
  • [49] Circulating tumor cells as prognostic marker in metastatic breast cancer
    Andreopoulou, Eleni
    Cristofanilli, Massimo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (02) : 171 - 177
  • [50] PARPBP is a prognostic marker and confers anthracycline resistance to breast cancer
    Chen, Bo
    Lai, Jianguo
    Dai, Danian
    Chen, Rong
    Liao, Ning
    Gao, Guanfeng
    Tang, Hailin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
12345